Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
assisTek, based on the extracted page content, is a provider of data collection solutions for decentralized clinical trials. It positions itself as an eSource platform for data collection in decentralized clinical trials and also offers eCOA and ePRO software. Its core value is helping clinical research teams collect clinical outcome assessment and patient-reported outcome data electronically, making it suitable for remote, decentralized, or hybrid clinical trial scenarios.
The currently identifiable modules include eSource, eCOA, and ePRO. eSource refers to electronic collection of clinical trial source data; eCOA is typically used for electronic clinical outcome assessments; and ePRO focuses on collecting patient self-reported data. The available text does not disclose details such as questionnaire design, visit management, device support, offline data capture, data verification, audit trails, permission management, or monitoring collaboration, so it would be inappropriate to infer further capabilities.
The website copy only mentions “Request a free demo today,” indicating that prospective customers can request a free demonstration. However, no information is provided about plans, pricing models, per-study pricing, per-subject pricing, module-based pricing, or custom enterprise quotes. It also does not state whether a free version or formal trial is available. For clinical trial software, actual procurement usually depends on study scale, compliance requirements, and service support, but these details are not disclosed in the available text.
The main strengths are its clear positioning, focus on decentralized clinical trial data collection, and coverage of high-demand areas such as eCOA/ePRO. The availability of a free demo also helps organizations conduct an initial evaluation before procurement. The main limitation is that public information is very limited: there are no details about third-party system integrations, APIs, data security and compliance, deployment options, team permissions, or customer support models. For pharmaceutical companies, CROs, or research institutions, these are key factors when evaluating an eClinical platform.
assisTek is better suited for clinical research teams, pharmaceutical companies, CROs, or medical research institutions that need to build data collection workflows for decentralized clinical trials. Since the extracted text does not include information about access from China, payment methods, localized services, or China-specific compliance, china_access can only be marked as unknown. Before using it in China, it is advisable to test website and system connectivity in practice and compare it with domestic eClinical, EDC, ePRO/eCOA, or clinical research digitalization platform alternatives.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on assistek.com official site.
assistek.com is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach assistek.com directly.